Computational design of peptide ligands

Drews, 2000, Drug discovery: a historical perspective, Science, 287, 1960, 10.1126/science.287.5460.1960 Arkin, 2004, Small-molecule inhibitors of protein–protein interactions: progressing towards the dream, Nat. Rev. Drug Discov., 3, 301, 10.1038/nrd1343 Wells, 2007, Reaching for high-hanging fruit in drug discovery at protein–-protein interfaces, Nature, 450, 1001, 10.1038/nature06526 Walsh, 2010, Biopharmaceutical benchmarks 2010, Nat. Biotechnol., 28, 917, 10.1038/nbt0910-917 Patel, 2007, Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives, Pharm. Res., 24, 1977, 10.1007/s11095-007-9303-7 Hopkins, 2002, The druggable genome, Nat. Rev. Drug Discov., 1, 727, 10.1038/nrd892 Lipinski, 2001, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev., 46, 3, 10.1016/S0169-409X(00)00129-0 Antosova, 2009, Therapeutic application of peptides and proteins: parenteral forever?, Trends Biotechnol., 27, 628, 10.1016/j.tibtech.2009.07.009 Tan, 2010, Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery, Peptides, 31, 184, 10.1016/j.peptides.2009.10.002 Audie, 2010, The synergistic use of computation, chemistry and biology to discover novel peptide-based drugs: the time is right, Curr. Pharm. Des., 16, 567, 10.2174/138161210790361425 Timmerman, 2005, Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces, Chembiochem, 6, 821, 10.1002/cbic.200400374 Walensky, 2004, Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix, Science, 305, 1466, 10.1126/science.1099191 Pechon, P. et al. (2010) 2010 Peptide Report – Development and Trends for Peptide Therapeutics, pp. 1–48 Pei, 2007, Reverse interactomics: decoding protein–protein interactions with combinatorial peptide libraries, Mol. Biosyst., 3, 536, 10.1039/B706041F Tonikian, 2008, A specificity map for the PDZ domain family, PLoS Biol., 6, e239, 10.1371/journal.pbio.0060239 Yin, 2007, Computational design of peptides that target transmembrane helices, Science, 315, 1817, 10.1126/science.1136782 Berman, 2000, The Protein Data Bank, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235 Stein, 2011, 3did: identification and classification of domain-based interactions of known three-dimensional structure, Nucleic Acid Res., 39, D718, 10.1093/nar/gkq962 Vanhee, 2010, PepX: a structural database of non-redundant protein–peptide complexes, Nucleic Acids Res., 38, D545, 10.1093/nar/gkp893 Vanhee, 2009, Protein–peptide interactions adopt the same structural motifs as monomeric protein folds, Structure, 17, 1128, 10.1016/j.str.2009.06.013 London, 2010, The structural basis of peptide–protein binding strategies, Structure, 18, 188, 10.1016/j.str.2009.11.012 Clackson, 1995, A hot spot of binding energy in a hormone–receptor interface, Science, 267, 383, 10.1126/science.7529940 Stein, 2010, Novel peptide-mediated interactions derived from high-resolution 3-dimensional structures, PLoS Comput. Biol., 6, e1000789, 10.1371/journal.pcbi.1000789 Stiffler, 2007, PDZ domain binding selectivity is optimized across the mouse proteome, Science, 317, 364, 10.1126/science.1144592 Reina, 2002, Computer-aided design of a PDZ domain to recognize new target sequences, Nat. Struct. Biol., 9, 621 Grigoryan, 2009, Design of protein-interaction specificity gives selective bZIP-binding peptides, Nature, 458, 859, 10.1038/nature07885 van der Sloot, 2006, Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor, Proc. Natl. Acad. Sci. U.S.A., 103, 8634, 10.1073/pnas.0510187103 Murray, 2010, Structural biology in fragment-based drug design, Curr. Opin. Struct. Biol., 20, 497, 10.1016/j.sbi.2010.04.003 Tanrikulu, 2008, Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening, Nat. Rev. Drug Discov., 7, 667, 10.1038/nrd2615 Giordano, 2010, From combinatorial peptide selection to drug prototype (I): targeting the vascular endothelial growth factor receptor pathway, Proc. Natl. Acad. Sci. U.S.A., 107, 5112, 10.1073/pnas.0915141107 Honeyman, 1998, Neural network-based prediction of candidate T-cell epitopes, Nat. Biotechnol., 16, 966, 10.1038/nbt1098-966 Lin, 2008, Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research, BMC Bioinform., 9, S22, 10.1186/1471-2105-9-S12-S22 Watt, 2006, Screening for peptide drugs from the natural repertoire of biodiverse protein folds, Nat. Biotechnol., 24, 177, 10.1038/nbt1190 Naider, 2009, Peptides in the treatment of AIDS, Curr. Opin. Struct. Biol., 19, 473, 10.1016/j.sbi.2009.07.003 Moellering, 2009, Direct inhibition of the NOTCH transcription factor complex, Nature, 462, 182, 10.1038/nature08543 Schafmeister, 2000, An all-hydrocarbon cross-linking system for enhancing the helicity and metabolic stability of peptides, J. Am. Chem. Soc., 122, 5891, 10.1021/ja000563a Stewart, 2010, The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer, Nat. Chem. Biol., 6, 595, 10.1038/nchembio.391 Jochim, 2009, Assessment of helical interfaces in protein–protein interactions, Mol. Biosyst., 5, 924, 10.1039/b903202a London, 2010, Can self-inhibitory peptides be derived from the interfaces of globular protein–protein interactions?, Proteins, 78, 3140, 10.1002/prot.22785 Craik, 2007, Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins, Expert Opin. Investig. Drugs, 16, 595, 10.1517/13543784.16.5.595 Gebauer, 2009, Engineered protein scaffolds as next-generation antibody therapeutics, Curr. Opin. Chem. Biol., 13, 245, 10.1016/j.cbpa.2009.04.627 Fernandez-Ballester, 2009, Structure-based prediction of the Saccharomyces cerevisiae SH3-ligand interactions, J. Mol. Biol., 388, 902, 10.1016/j.jmb.2009.03.038 Smith, 2010, Structure-based prediction of the peptide sequence space recognized by natural and synthetic PDZ domains, J. Mol. Biol., 402, 460, 10.1016/j.jmb.2010.07.032 Raveh, 2010, Sub-angstrom modeling of complexes between flexible peptides and globular proteins, Proteins, 78, 2029, 10.1002/prot.22716 King, 2010, Structure-based prediction of protein–peptide specificity in Rosetta, Proteins, 78, 3437, 10.1002/prot.22851 Petsalaki, 2009, Accurate prediction of peptide binding sites on protein surfaces, PLoS Comput. Biol., 5, e1000335, 10.1371/journal.pcbi.1000335 Abe, 2007, Peptide ligand screening of alpha-synuclein aggregation modulators by in silico panning, BMC Bioinform., 8, 451, 10.1186/1471-2105-8-451 Unal, 2010, VitAL: Viterbi algorithm for de novo peptide design, PLoS ONE, 5, e10926, 10.1371/journal.pone.0010926 Walters, 2006, Helix-packing motifs in membrane proteins, Proc. Natl. Acad. Sci. U.S.A., 103, 13658, 10.1073/pnas.0605878103 Baeten, 2008, Reconstruction of protein backbones from the BriX collection of canonical protein fragments, PLoS Comput. Biol., 4, e1000083, 10.1371/journal.pcbi.1000083 Vanhee, 2010, BriX: a database of protein building blocks for structural analysis, modeling and design, Nucleic Acids Res., 31, D435 Kliger, 2009, Peptides modulating conformational changes in secreted chaperones: from in silico design to preclinical proof of concept, Proc. Natl. Acad. Sci. U.S.A., 106, 13797, 10.1073/pnas.0906514106 Hayouka, 2007, Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium, Proc. Natl. Acad. Sci. U.S.A., 104, 8316, 10.1073/pnas.0700781104 van der Sloot, 2009, Protein design in biological networks: from manipulating the input to modifying the output, Protein Eng. Des. Sel., 22, 537, 10.1093/protein/gzp032 Kaufmann, 2010, Practically useful: what the Rosetta protein modeling suite can do for you, Biochemistry, 49, 2987, 10.1021/bi902153g Schymkowitz, 2005, The FoldX web server: an online force field, Nucleic Acids Res., 33, W382, 10.1093/nar/gki387 Link, 2003, Non-canonical amino acids in protein engineering, Curr. Opin. Biotechnol., 14, 603, 10.1016/j.copbio.2003.10.011 Moult, 2005, A decade of CASP: progress, bottlenecks and prognosis in protein structure prediction, Curr. Opin. Struct. Biol., 15, 285, 10.1016/j.sbi.2005.05.011 Janin, 2005, Assessing predictions of protein–protein interaction: the CAPRI experiment, Protein Sci., 14, 278, 10.1110/ps.041081905 Brunton, 2006 Smith, 2006, Exploring protein–ligand recognition with Binding MOAD, J. Mol. Graph. Model., 24, 414, 10.1016/j.jmgm.2005.08.002 Lo Conte, 1999, The atomic structure of protein–protein recognition sites, J. Mol. Biol., 285, 2177, 10.1006/jmbi.1998.2439 Jones, 1996, Principles of protein–protein interactions, Proc. Natl. Acad. Sci. U.S.A., 93, 13, 10.1073/pnas.93.1.13 Reichmann, 2005, The modular architecture of protein–protein binding interfaces, Proc. Natl. Acad. Sci. U.S.A., 102, 57, 10.1073/pnas.0407280102 Thorsen, 2010, Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD, Proc. Natl. Acad. Sci. U.S.A., 107, 413, 10.1073/pnas.0902225107 Conn, 2009, Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders, Nat. Rev. Drug Discov., 8, 41, 10.1038/nrd2760 Eglen, 2010, Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors, Expert Opin. Drug Discov., 5, 277, 10.1517/17460441003636820 Alvarado, 2010, Structural basis for negative cooperativity in growth factor binding to an EGF receptor, Cell, 142, 568, 10.1016/j.cell.2010.07.015 Lee, 2008, Surface sites for engineering allosteric control in proteins, Science, 322, 438, 10.1126/science.1159052 Lenaerts, 2009, Protein domains as information processing units, Curr. Protein Pept. Sci., 10, 133, 10.2174/138920309787847626 Haliloglu, 2009, Analysis of correlations between energy and residue fluctuations in native proteins and determination of specific sites for binding, Phys. Rev. Lett., 102, 88103, 10.1103/PhysRevLett.102.088103 Haliloglu, 2010, Predicting important residues and interaction pathways in proteins using Gaussian Network Model: binding and stability of HLA proteins, PLoS Comput. Biol., 6, e1000845, 10.1371/journal.pcbi.1000845 Sugahara, 2010, Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs, Science, 328, 1031, 10.1126/science.1183057 Weng, 2003, Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling, Mol. Cell. Biol., 23, 655, 10.1128/MCB.23.2.655-664.2003 Nam, 2006, Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes, Cell, 124, 973, 10.1016/j.cell.2005.12.037 Sheridan, 2010, Roche backs Aileron's stapled peptides, Nat. Biotechnol., 28, 992, 10.1038/nbt1010-992c Desgrosellier, 2010, Integrins in cancer: biological implications and therapeutic opportunities, Nat. Rev. Cancer, 10, 9, 10.1038/nrc2748 Yin, 2007, Computational design of peptides that target transmembrane helices, Science, 315, 1817, 10.1126/science.1136782